Evidence map›Paper›PMID 29110985›Full record

ReviewBioorganic & medicinal chemistry letters2017

Cyclotides, a versatile ultrastable micro-protein scaffold for biotechnological applications.

Julio A Camarero

Open access · greenAbstract readReview
In one paragraph

Review in Bioorganic & medicinal chemistry letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Plant derived cyclic peptides.Biochemical Society transactions · 2021
    Review
  12. Article
  13. Recombinant Expression of Cyclotides Using Expressed Protein Ligation.Methods in molecular biology (Clifton, N.J.) · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Julio A CamareroDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089-9121, USA; Department of Chemistry, University of Southern California, Los Angeles, CA 90089-9121, USA. Electronic address: jcamarer@usc.edu.
University of Southern California · US

Funding

Cell-based screening and selection of cyclotide-based capture reagents for proteiR01GM090323 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CAMARERO, JULIO A · 2009 to 2013
$2.0M
Screening and selection of specific protein-protein antagonists using ultrastable microprotein scaffoldsR01GM113636 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CAMARERO, JULIO A · 2015 to 2018
$1.3M
NIGMS NIH HHS R01 GM090323NIGMS NIH HHS R01 GM113636
6 · The paper itself

Abstract

Cyclotides are fascinating microproteins (≈30-40 residues long) with a unique head-to-tail cyclized backbone, stabilized by three disulfide bonds forming a cystine knot. This unique topology makes them exceptionally stable to chemical, thermal and biological degradation compared to other peptides of similar size. Cyclotides have been also found to be highly tolerant to sequence variability, aside from the conserved residues forming the cystine knot, able to cross cellular membranes and modulate intracellular protein-protein interactions both in vitro and in vivo. These properties make them ideal scaffolds for many biotechnological applications. This article provides and overview of the properties of cyclotides and their applications as molecular imaging agents and peptide-based therapeutics.

Indexed as

AnimalsContrast MediaCyclotidesDrug DesignPlant ProteinsPositron Emission Tomography Computed TomographyProtein Structure, TertiaryRecombinant ProteinsContrast MediaCyclotideskalata B1Plant ProteinsRecombinant Proteinstrypsin inhibitor MCoTI-IIBioimaging agentsCircular proteinCyclotideCystine knotDrug designKalata B1MCoTI-I

Identifiers

PMID29110985
PMCPMC5812341
OpenAlexW2766078662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.